Matching cardiac rhythm management technology to patient needs: Pacing/ablation/implantable cardioverter defibrillators

American Journal of Cardiology

Volumn 86, Issue 9 SUPPL. 1, 2000, Pages K58-K70

  Cannom, David S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL; VERAPAMIL;

CATHETER ABLATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; DEFIBRILLATION; DEFIBRILLATOR; HEART DEATH; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE PACING; HIGH RISK PATIENT; HUMAN; MORTALITY; PATIENT CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; SUDDEN DEATH; SURGICAL APPROACH; SURVIVAL RATE; TREATMENT INDICATION;

EID: 0034597566     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01293-5     Document Type: Conference Paper

References (74)

1. Influence implantable cardioverter defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest
2. Sudden death in high-risk family members: Brugada syndrome
3. 3: A marker for sudden death in patients without demonstrable structural heart disease
4. Electrophysiologic-electropharmacologic testing in patients with ventricular arrhythmias
5. Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias
6. Recurrent sustained ventricular tachycardia: Role of the electrophysiologic study in selection of antiarrhythmic regimens
7. Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease
8. Out-of-hospital cardiac arrest: Use of electrophysiologic testing in the prediction of long-term outcome
9. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: Criteria of efficacy in patients with sustained ventricular tachyarrhythmia
10. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest
11. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal sustained ventricular arrhythmias
12. A randomized study of the prevention of sudden death in patients with coronary artery disease
13. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
14. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs
15. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia
16. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias
17. Management of ventricular arrhythmias: Detection, drugs and devices
18. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction
19. Prognostic significance of late ventricular potentials after acute myocardial infarction
20. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction
21. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: Based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring
22. Prediction of serious arrhythmic events after myocardial infarction: Signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography
23. Standards for analysis of ventricular late potentials using high-resolution signal-averaged electrocardiography: A statement by a Task Force Committee of the European Society of Cardiology, The American Heart Association, and the American College of Cardiology
24. Heart rate variability: Standards of measurement, physiological interpretation and clinical use
25. Respiratory sinus arrhythmia: A noninvasive measure of parasympathetic cardiac control
26. The value of cardiovascular autonomic function tests: 10 Years' experience in diabetes
27. Simple bed side test of one minute heart rate variability during deep breathing predicts mortality after myocardial infarction
28. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat to beat cardiovascular control
29. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
30. Alternating morphology of the QRST complex preceding sudden death
31. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals
32. Prognosis after myocardial infarction
33. Ventricular premature beats and mortality after myocardial infarction
34. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction
35. SCD-HeFT: Prevention of sudden cardiac death in patients with congestive heart failure trial
36. Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and clinical protocol
37. The DEFINITE trial: Pharmacoeconomic impact of prophylactic ICD implantation in nonischemic cardiomyopathy
38. Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry
39. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: A critical review of the Antiarrhythmics Versus Implantable Defibrillator Trial and the Canadian Implantable Defibrillator Study
40. Mortality in patients with implanted automatic defibrillators
41. Long term outcome with the automatic implantable cardioverter defibrillator
42. Implantable defibrillation: Eight years clinical experience
43. Clinical article on patients with malignant ventricular tachyarrhythmias and a multi-programmable implantable cardioverter-defibrillator implanted with or without thoracotomy
44. Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy
45. Patient selection criteria and results of surgery for refractory ischemic ventricular tachycardia
46. Catheter ablation of ventricular tachycardia
47. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease
48. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction
49. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease
50. Catheter ablation of ventricular tachycardia in 136 patients with coronary disease. Results of long-term followup
51. A perspective on the ESVEM Trial and current knowledge: Catheter ablation for ventricular tachyarrhythmias
52. A randomized trial of propranolol in patients with acute myocardial infarction: Mortality results
53. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
54. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
55. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
56. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
57. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure
58. A clinical trial of the ACE inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
59. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
60. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
61. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy
62. Screening and therapy for patients with nonsustained ventricular tachycardia
63. Unsustained ventricular tachycardia: To treat or not to treat
64. International survey of prophylactic defibrillator implantation
65. Estimating the proportion of post-myocardial infarction patients who may benefit from prophylactic implantable defibrillator placement from analysis of the CAST registry: Cardiac Arrhythmia Suppression Trial
66. Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhythmias
67. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial
68. Sudden cardiac death
69. Long-term survival in the cardiac arrest study Hamburg
70. Which strategy is 'best' after myocardial infarction? The beta blocker strategy plus implantable cardioverter defibrillator trial: Rationale and study design
71. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
72. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)